Ingredient Callouts: Free of parabens, formaldehydes, formaldehyde-releasing agents, phthalates, mineral oil, retinyl palmitate, oxybenzone, coal tar, hydroquinone, sulfates SLS & SLES, triclocarban, and triclosan
Phase 2 clinical trial data showed an average of 24.2% total body weight reduction at the 12mg dose over 48 weeks, which makes Retatrutide the most effective compound of its type by a meaningful margin
Introduction Embarking on a weight loss journey is a significant personal commitment, often filled with anticipation and hope
Current FDA approval status As of April 2026, retatrutide is not FDA approved
In one embodiment, the pH is about 4 to about 4.5
The FLOW trial set out to assess the efficacy and safety of semaglutide for the prevention of kidney failure, substantial loss of kidney function and death from kidney-related or cardiovascular causes in people with type 2 diabetes and CKD